Influence of Diet on Pregnancy With Polyhydramnios

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03277417` - Does Amniotic Fluid Index Affect the Fetal Cardiac Performance?	N/A
Completed	`NCT05059093` - Developing and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans.
Not yet recruiting	`NCT05043753` - "Fetal gRowth AbnorMality dEtection Trial"	N/A
Completed	`NCT00236340` - Syringe or Continuous Amnioreduction for Symptomatic Polyhydramnios. A Prospective Randomized Study.	Phase 3

See also

Status

Clinical Trial

Phase

Not yet recruiting

NCT03277417 - Does Amniotic Fluid Index Affect the Fetal Cardiac Performance?

N/A

Completed

NCT05059093 - Developing and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans.

Not yet recruiting

NCT05043753 - "Fetal gRowth AbnorMality dEtection Trial"

N/A

Completed

NCT00236340 - Syringe or Continuous Amnioreduction for Symptomatic Polyhydramnios. A Prospective Randomized Study.

Phase 3

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04497532
Study type	Interventional
Source	Wolfson Medical Center
Contact	Liliya Tamayev, MD
Phone	+972532343882
Email	t_liki@yahoo.com
Status	Not yet recruiting
Phase	N/A
Start date	March 20, 2021
Completion date	December 20, 2022

Influence of Diet on Pregnancy With Polyhydramnios

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms